Shimizu Y - Search Results

1

YM-341619 suppresses the differentiation of spleen T cells into Th2 cells in vitro, eosinophilia, and airway hyperresponsiveness in rat allergic models.

Ohga K, Kuromitsu S, Takezawa R, Numazaki M, Ishikawa J, Nagashima S, Shimizu Y. Ohga K, et al. Among authors: shimizu y. Eur J Pharmacol. 2008 Aug 20;590(1-3):409-16. doi: 10.1016/j.ejphar.2008.06.035. Epub 2008 Jun 14. Eur J Pharmacol. 2008. PMID: 18590722

2

The suppressive effects of YM-58483/BTP-2, a store-operated Ca2+ entry blocker, on inflammatory mediator release in vitro and airway responses in vivo.

Ohga K, Takezawa R, Yoshino T, Yamada T, Shimizu Y, Ishikawa J. Ohga K, et al. Among authors: shimizu y. Pulm Pharmacol Ther. 2008;21(2):360-9. doi: 10.1016/j.pupt.2007.09.003. Epub 2007 Oct 2. Pulm Pharmacol Ther. 2008. PMID: 17977764

3

Characterization of YM-58483/BTP2, a novel store-operated Ca2+ entry blocker, on T cell-mediated immune responses in vivo.

Ohga K, Takezawa R, Arakida Y, Shimizu Y, Ishikawa J. Ohga K, et al. Among authors: shimizu y. Int Immunopharmacol. 2008 Dec 20;8(13-14):1787-92. doi: 10.1016/j.intimp.2008.08.016. Epub 2008 Sep 13. Int Immunopharmacol. 2008. PMID: 18793756

4

Inhibition of antigen-induced airway inflammation and hyperresponsiveness in guinea pigs by a selective antagonist of "chemoattractant receptor homologous molecule expressed on Th2 cells" (CRTH2).

Tasaki M, Kobayashi M, Tenda Y, Tsujimoto S, Nakazato S, Numazaki M, Hirano Y, Matsuda H, Terasaka T, Miyao Y, Shimizu Y, Hirayama Y. Tasaki M, et al. Among authors: shimizu y. Eur J Pharm Sci. 2013 Jun 14;49(3):434-40. doi: 10.1016/j.ejps.2013.04.017. Epub 2013 Apr 24. Eur J Pharm Sci. 2013. PMID: 23624353

5

The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo.

Yamamoto S, Sugahara S, Naito R, Ichikawa A, Ikeda K, Yamada T, Shimizu Y. Yamamoto S, et al. Among authors: shimizu y. Eur J Pharmacol. 2006 Jul 10;541(1-2):106-14. doi: 10.1016/j.ejphar.2006.05.007. Epub 2006 May 12. Eur J Pharmacol. 2006. PMID: 16780833

6

A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.

Suzuki K, Morokata T, Morihira K, Sato I, Takizawa S, Kaneko M, Takahashi K, Shimizu Y. Suzuki K, et al. Among authors: shimizu y. Eur J Pharmacol. 2007 Jun 1;563(1-3):224-32. doi: 10.1016/j.ejphar.2007.01.074. Epub 2007 Feb 8. Eur J Pharmacol. 2007. PMID: 17336292

7

Therapeutic potential of ASP3258, a selective phosphodiesterase 4 inhibitor, on chronic eosinophilic airway inflammation.

Kobayashi M, Kubo S, Shiraki K, Iwata M, Hirano Y, Ohtsu Y, Takahashi K, Shimizu Y. Kobayashi M, et al. Among authors: shimizu y. Pharmacology. 2012;90(3-4):223-32. doi: 10.1159/000342380. Epub 2012 Sep 13. Pharmacology. 2012. PMID: 23038661

8

Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models.

Yamamoto S, Sugahara S, Ikeda K, Shimizu Y. Yamamoto S, et al. Among authors: shimizu y. Eur J Pharmacol. 2006 Nov 21;550(1-3):166-72. doi: 10.1016/j.ejphar.2006.08.023. Epub 2006 Aug 30. Eur J Pharmacol. 2006. PMID: 17010967

., Sugahara, S., Naito, R., Ichikawa, A., Ikeda, K., Yamada, T., Shimizu, Y., 2006. The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo. ...

., Sugahara, S., Naito, R., Ichikawa, A., Ikeda, K., Yamada, T., Shimizu, Y., 2006. The effects of a novel phosphodiesterase 7 …

9

Amelioration of collagen-induced arthritis in mice by a novel phosphodiesterase 7 and 4 dual inhibitor, YM-393059.

Yamamoto S, Sugahara S, Ikeda K, Shimizu Y. Yamamoto S, et al. Among authors: shimizu y. Eur J Pharmacol. 2007 Mar 22;559(2-3):219-26. doi: 10.1016/j.ejphar.2006.11.079. Epub 2006 Dec 12. Eur J Pharmacol. 2007. PMID: 17250824

., Sugahara, S., Naito, R., Ichikawa, A., Ikeda, K., Yamada, T., Shimizu, Y., 2006. The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo. ...

., Sugahara, S., Naito, R., Ichikawa, A., Ikeda, K., Yamada, T., Shimizu, Y., 2006. The effects of a novel phosphodiesterase 7 …

10

Disease-modifying effect of ASP3258, a novel phosphodiesterase type 4 inhibitor, on subchronic cigarette smoke exposure-induced lung injury in guinea pigs.

Kubo S, Kobayashi M, Iwata M, Takahashi K, Miyata K, Shimizu Y. Kubo S, et al. Among authors: shimizu y. Eur J Pharmacol. 2011 May 20;659(1):79-84. doi: 10.1016/j.ejphar.2011.02.042. Epub 2011 Mar 5. Eur J Pharmacol. 2011. PMID: 21385578

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,003 results

Search Page